Correlation Between Eyenovia and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both Eyenovia and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eyenovia and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eyenovia and Eliem Therapeutics, you can compare the effects of market volatilities on Eyenovia and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eyenovia with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eyenovia and Eliem Therapeutics.
Diversification Opportunities for Eyenovia and Eliem Therapeutics
0.5 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Eyenovia and Eliem is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Eyenovia and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Eyenovia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eyenovia are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Eyenovia i.e., Eyenovia and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between Eyenovia and Eliem Therapeutics
Given the investment horizon of 90 days Eyenovia is expected to under-perform the Eliem Therapeutics. In addition to that, Eyenovia is 3.71 times more volatile than Eliem Therapeutics. It trades about -0.31 of its total potential returns per unit of risk. Eliem Therapeutics is currently generating about -0.29 per unit of volatility. If you would invest 411.00 in Eliem Therapeutics on August 28, 2024 and sell it today you would lose (111.00) from holding Eliem Therapeutics or give up 27.01% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.24% |
| Values | Daily Returns |
Eyenovia vs. Eliem Therapeutics
Performance |
| Timeline |
| Eyenovia |
| Eliem Therapeutics |
Eyenovia and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eyenovia and Eliem Therapeutics
The main advantage of trading using opposite Eyenovia and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eyenovia position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.| Eyenovia vs. Reviva Pharmaceuticals Holdings | Eyenovia vs. Cidara Therapeutics | Eyenovia vs. Fortress Biotech | Eyenovia vs. Reviva Pharmaceuticals Holdings |
| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |